Themis Medicare Faces Significant Decline Amid Broader Market Challenges and Trend Reversal

Themis Medicare, a small-cap player in the Pharmaceuticals & Drugs sector, has experienced a significant decline of 7.05% on April 4, 2025. This drop comes after a brief period of gains, marking a trend reversal as the stock fell following three consecutive days of increases. The stock is currently trading close to its 52-week low, just 2.8% above Rs 142.4.
In terms of performance metrics, Themis Medicare has underperformed its sector, which has seen an overall decline of 5.2%. The stock's intraday low reached Rs 146, reflecting a 7.3% decrease. Additionally, Themis Medicare is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.

The broader market context shows the Sensex has also faced challenges, falling sharply by 696.72 points to 75,463.37, a decline of 1.09%. The stock's performance over various time frames reveals a stark contrast to the Sensex, with Themis Medicare showing a year-to-date decline of 44.04% compared to the Sensex's 3.42% drop. Over the past three years, however, Themis Medicare has outperformed the Sensex with a 49.42% increase.